Moderate Genetic Diversity with Extensive Antimicrobial Resistance Among Multidrug-Resistant Acinetobacter baumannii in a Referral Hospital in Northeast Iran

被引:4
|
作者
Mosavat, Arman [1 ]
Soleimanpour, Saman [2 ,3 ]
Farsiani, Hadi [2 ,3 ]
Salimizand, Himen [4 ]
Kebriaei, Abdollah [5 ]
Jamehdar, Saeid Amel [2 ,3 ]
Bagheri, Mahmoud [2 ,3 ]
Rezaee, Seyed Abdolrahim [6 ]
Ghazvini, Kiarash [2 ,3 ]
机构
[1] ACECR, Blood Borne Infect Res Ctr, Razavi Khorasan, Mashhad, Iran
[2] Mashhad Univ Med Sci, Antimicrobial Resistance Res Ctr, Bu Ali Res Inst, Mashhad, Iran
[3] Mashhad Univ Med Sci, Dept Microbiol & Virol, Fac Med, Mashhad, Iran
[4] Kurdistan Univ Med Sci, Dept Microbiol, Fac Med, Sanandaj, Iran
[5] North Khorasan Univ Med Sci, Dept Microbiol & Virol, Fac Med, Bojnord, Iran
[6] Mashhad Univ Med Sci, Inflammat & Inflammatory Dis Div, Immunol Res Ctr, Mashhad, Iran
关键词
Acinetobacter baumannii; Drug Resistance; Infection Prevention and Control; Molecular Epidemiology; Minimum Inhibitory Concentration; Polymerase Chain Reaction; MOLECULAR EPIDEMIOLOGY; NOSOCOMIAL OUTBREAK; MULTIPLEX PCR; BETA-LACTAMASES; EFFLUX PUMPS; STRAINS; PREVALENCE; IDENTIFICATION; CARBAPENEMASE; ASSOCIATION;
D O I
10.5812/jjm.14412
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Acinetobacter baumannii is one of the major opportunistic pathogens with increasing clinical significance, particularly in the Hospital setting. Objectives: The study aimed to analyze the antibiotic resistance determinants in multidrug-resistant A. baumannii (MDRAB) isolates collected after an outbreak, with regard to the infection prevention control (IPC) interventions to eradicate the outbreak. Methods: Thirty nine isolates of MDRAB were collected during six months of the study after the outbreak. Infection prevention control was successful only for the first three months after the intervention. Antimicrobial susceptibility testing and minimum inhibitory concentrations (MICs) were determined by E-test. In addition, various resistance genes and the clonal relatedness of the isolates were performed by PCR and REP-PCR. Results: All isolates were MDRAB while being susceptible to colistin. The prevalence of bla(ADC), bla(TEM), blaOX(A24), bla(VIM), and bla(IMP) was 82%, 100%, 70%, 61%, and 5%, respectively. bla(OXA51), bla(OXA23), and ISAba1 were detected in all isolates, but bla(OXA58) was not. Moreover, ISAba1 was located upstream to bla(OXA23) and blaADC in 100% and 38.4% of the isolates, respectively. The most prevalent AME was aadB (100%). Even though adeB and tetB efflux pumps were found in 100% and 95% of the isolates, respectively, tetA was not characterized. REP-PCR revealed five clusters of which, approximately 51% of the strains belonged to cluster C. Conclusions: Regarding the molecular approach, the effectiveness of IPC and epidemiological context has been identified. Stringent infection-control measures are urgent to restrict the outbreak.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Multidrug-Resistant Acinetobacter baumannii: Risk Factors for Mortality in a Tertiary Care Teaching Hospital
    Cerniauskiene, Kristina
    Vitkauskiene, Astra
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2025, 10 (01)
  • [42] Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii
    Mak, Jennifer K.
    Kim, Mi-Jurng
    Pham, Jeanette
    Tapsall, John
    White, Peter A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 47 - 54
  • [43] Multidrug-resistant Acinetobacter baumannii bacteraemia:: clinical features, antimicrobial therapy and outcome
    Kuo, L. -C.
    Lai, C. -C.
    Liao, C. -H.
    Hsu, C. -K.
    Chang, Y. -L.
    Chang, C. -Y.
    Hsueh, P. -R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (02) : 196 - 198
  • [44] Emergence of blaOXA-Carrying Carbapenem Resistance in Multidrug-Resistant Acinetobacter baumannii in the Intensive Care Unit
    Josheghani, Sareh Bagheri
    Moniri, Rezvan
    Firoozeh, Farzaneh
    Sehat, Mojtaba
    Dastehgoli, Kamran
    Koosha, Hasan
    Farahani, Reza Khaltabadi
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2017, 19 (05)
  • [45] Analysis and Forecast for Multidrug-Resistant Acinetobacter baumannii Infections Among Liver Transplant Recipients
    Guo, W.
    Sheng, J.
    Gu, Y.
    Xing, T. -H.
    Peng, Z. -H.
    Zhong, L.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (05) : 1448 - 1452
  • [46] The Prevalence of Multidrug-Resistant Acinetobacter baumannii and Its Vaccination Status among Healthcare Providers
    Elbehiry, Ayman
    Marzouk, Eman
    Moussa, Ihab
    Mushayt, Yazeed
    Algarni, Ahmad Abdullah
    Alrashed, Osama Ali
    Alghamdi, Khalid Saad
    Almutairi, Naif Ahmed
    Anagreyyah, Sulaiman Abdulaziz
    Alzahrani, Anwar
    Almuzaini, Abdulaziz M.
    Alzaben, Feras
    Alotaibi, Meshal Abdullah
    Anjiria, Suha Abdulaziz
    Abu-Okail, Akram
    Abalkhail, Adil
    VACCINES, 2023, 11 (07)
  • [47] Antimicrobial resistance, virulence gene profiling, and genetic diversity of multidrug-resistant Pseudomonas aeruginosa isolates in Mazandaran, Iran
    Elahi, Ghazaleh
    Goli, Hamid Reza
    Shafiei, Morvarid
    Nikbin, Vajihe Sadat
    Gholami, Mehrdad
    BMC MICROBIOLOGY, 2024, 24 (01):
  • [48] Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt
    Jalal, Deena
    Elzayat, Mariam G.
    Diab, Aya A.
    El-Shqanqery, Hend E.
    Samir, Omar
    Bakry, Usama
    Hassan, Reem
    Elanany, Mervat
    Shalaby, Lobna
    Sayed, Ahmed A.
    MSPHERE, 2021, 6 (06)
  • [49] Outbreak of Multidrug-Resistant Acinetobacter baumannii ST208 Producing OXA-23-Like Carbapenemase in a Children's Hospital in Shanghai, China
    Wang, Xing
    Du, Zhuoying
    Huang, Weichun
    Zhang, Xingyu
    Zhou, Yun
    MICROBIAL DRUG RESISTANCE, 2021, 27 (06) : 816 - 822
  • [50] Burden of Multidrug-Resistant Acinetobacter baumannii Infection in Hospitalized Patients in a Tertiary Care Hospital of Nepal
    Yadav, Santosh Kumar
    Bhujel, Rajshree
    Hamal, Pradip
    Mishra, Shyam Kumar
    Sharma, Sangita
    Sherchand, Jeevan Bahadur
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 725 - 732